These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20396485)

  • 21. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Utility of the Combined Use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Yonago Acta Med; 2018 Jun; 61(2):117-127. PubMed ID: 29946218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
    Yoshita M
    J Neurol Sci; 1998 Feb; 155(1):60-7. PubMed ID: 9562324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.
    Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T
    J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIBG myocardial scintigraphy in progressive supranuclear palsy.
    Kamada T; Miura S; Kida H; Irie KI; Yamanishi Y; Hoshino T; Taniwaki T
    J Neurol Sci; 2019 Jan; 396():3-7. PubMed ID: 30391822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
    Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
    Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
    Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
    Miyamoto T; Miyamoto M; Suzuki K; Nishibayashi M; Iwanami M; Hirata K
    Sleep; 2008 May; 31(5):717-23. PubMed ID: 18517041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease.
    Mochizuki H; Ebihara Y; Ugawa Y; Ishii N; Taniguchi A; Nagamachi S; Shiomi K; Nakazato M
    Eur Neurol; 2015; 74(1-2):107-11. PubMed ID: 26303385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
    Iwabuchi Y; Kameyama M; Matsusaka Y; Narimatsu H; Hashimoto M; Seki M; Ito D; Tabuchi H; Yamada Y; Jinzaki M
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1833-1841. PubMed ID: 33392714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
    Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Utility of Segmental Analysis in Cardiac I-123 MIBG SPECT in Parkinson's Disease.
    Kwon SH; Yoon JK; Yoon JH; Lee SJ; Jo KS; Lee DH; An YS
    Nucl Med Mol Imaging; 2015 Dec; 49(4):298-302. PubMed ID: 26550049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
    Brandl SJ; Braune S
    Clin Auton Res; 2019 Dec; 29(6):567-574. PubMed ID: 29869732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.